86-027-88210112
Product name :LGD-4033
Alias: Ligandrol
CAS: 1165910-22-4
MF: C14h12f6n2o
MW: 338.2482992
Appearance :White crystalline powder
Usage: LGD-4033 (Ligandrol) is a selective oral androgen receptor modulator (SARM). It is in a class of androgen receptor (AR) ligands that are tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss .
LGD-4033 (anabolicum) is the strongest in its class selective androgen receptor modulator (SARM). As a matter of fact, it is one of the newest SARMs that have come out, and is the closest SARM that can be equated to an anabolic steroid when it comes to pure strength. Hence, it is the strongest SARM mg for mg in terms of the mass you can put on.
Description of LGD-4033
LGD-4033, a novel nonsteroidal, oral selective androgen receptor modulator, binds to the androgen receptor with high affinity and selectivity. It demonstrates anabolic activity in muscles, anti-resorptive and anabolic activity in bones and a robust selectivity for muscle and bone versus prostate and sebaceous glands. LGD-4033 has recently completed a Phase I Multiple Ascending Dose study in healthy volunteers. This randomized, double-blind, placebo-controlled Phase I study established the safety and tolerability up to doses of 22 mg per day.
LGD is still fairly new (3-5 years), but the results have been very similar in studies and logs. LGD-4033 has undergone several recent studies and trials to find the best and safest way to use it. From these trials, the results have shown increases in lean body mass and decreases in body fat. There is also a significant increase in strength, well being, as well as healing possibilities.
What is LGD-4033 ?
LGD-4033 is a selective androgen receptor modulator (SARMS), and a novel non-steroidal oral SARM that binds to AR with high affinity (Ki of ~1 nM) and selectivity. It's in a class of androgen receptor (AR) ligands that is tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss. LGD-4033 is expected to produce the therapeutic benefits of testosterone with improved safety, tolerability and patient acceptance due to tissue-selective mechanism of action and an oral route of administration.
How it works
LGD-4033, a novel nonsteroidal, oral selective androgen receptor modulator, binds to the androgen receptor with high affinity and selectivity. It demonstrates anabolic activity in muscles, anti-resorptive and anabolic activity in bones and a robust selectivity for muscle and bone versus prostate and sebaceous glands. LGD-4033 has recently completed a Phase I Multiple Ascending Dose study in healthy volunteers. This randomized, double-blind, placebo-controlled Phase I study established the safety and tolerability up to doses of 22 mg per day.
Anabolicum works by binding to androgen receptors selectively, meaning that it creates anabolic activity only in bones and muscles, instead of harming prostate and sebaceous glands, like anabolic steroids do. In fact, volunteer human studies have shown that LGD 4033 was harmless when used with a dose under 22 milligrams (mg) per day. Furthermore, studies also showed that LGD enhances lean muscle mass and decreases body fat; all of which comes with an incredible ability to boost strength, recovery and overall health.
How to use LGD-4033 ?
For Bulking :
LGD has shown the most ability of any SARM to put on size that could be considered a bulk. This will, of course, be dependent upon the diet used. Users that have experienced more than 10lb. increases, and have had a significant increase in calorie intake. The possibility of this type of size is present with LGD use. A recommend dosage for this type of goal would be 5-10 mg day for 8 weeks.
For Recomp :
LGD seems to shine with this method. Many have seen an increase in lean body mass and a decrease in body fat. LGD seems to work the best with this method. Ran in conjunction with other SARMS, like cardarine (GW-501516), will only increase the likelihood of a stronger recomp. Recommended doses for recomping would be 5-8 mg a day for 8 weeks.
For Cutting :
LGD can be used to cut as well. It will shine more-so if ran in conjunction with SARMS S-4 and Cardarine (GW-501516). This would be similar to a SARMS triple stack that is normally ran with Ostarine, except there is a possibility of more size being put on while cutting. A good dose for this method would be 3-5 mg a day for 8 weeks.
The effect of LGD-4033 :
Effects similar to anabolics with size and strength
Minimal Side Effects
Excellent for recomping
Healing properties
Prevents muscle wasting
Works well as a stand alone or stacked with other SARMS
Great results in every aspect for different types of goals
Half life of 24-36 hours
Our Sarms lists :
Ostarine,MK-2866, Enobosarm
Andarine (GTX-007)
MK-677, Ibutamoren
LGD-4033
GW-501516(cardarine)
SR9009
Andarine / S4
YK11
Aicar
Sunifiram(DM-235)
RAD140
Welcome to contact Miss Alsia
Skype:live:mxy04
Whatsapp:+8615107134681
Mobilephone:+8615107134681
facebook:www.facebook.com/alisa.lee.58118
Email:marc@chembj.com